Abbott Precision XceedPro Manuel de l'opérateur Page 2

  • Télécharger
  • Ajouter à mon manuel
  • Imprimer
  • Page
    / 20
  • Table des matières
  • DEPANNAGE
  • MARQUE LIVRES
  • Noté. / 5. Basé sur avis des utilisateurs
Vue de la page 1
Title (with LTR): Precision Xceed Glucose Procedure (LTR19678)
Last Approved: Gregory, Kimberly (Electronic Signature Timestamp: 8/11/2014 3:20:23 PM)
2
Purpose
This document outlines policies and procedures that deal with the test being described. In an effort to be concise
some information may be excluded from the manufacturer’s manual. It is recommended that operators familiarize
themselves with the manufacturer’s product information that accompanies each package and their manual.
Scope
Level of Personnel: All MD’s, RNs, NPs, PCAs, and
MAs, who have successfully completed initial training and
maintained annual competency.
Testing Site: All sites approved and on file with the
Pathology Service POCT Division.
Policy and Principle Statement
To obtain a quantitative measure of blood glucose measurement that is used definitively for the purpose of care.
Test Principle
The Precision Xceed Pro System allows rapid measurement of blood glucose (D-glucose) by using an electrochemical
detection technique. This biosensor system employs a disposable dry reagent strip technology, based on the glucose
dehydrogenase method for glucose determination. Each test strip features an electrode containing the enzyme
glucose dehydrogenase (GDH-NAD). When a blood drop is applied to the target area of the test strip, the glucose
dehydrogenase catalyzes the oxidation of glucose in the drop to produce gluconic acid. During the reaction, electrons
are transferred by a co-enzyme and an electrochemical mediator to the electrode surface. This will generate a current
that is measured by the system. The size of the current generated is proportional to the amount of glucose present in
the blood drop, thus giving an accurate reading of the blood glucose concentration.
Regulatory Requirements
1. Each testing site must have a documented quality control program, which is developed in collaboration with or
has been approved by the MGH Pathology Service.
2. All test results must be maintained in patient records with all required information for four years
Required information:
1. Patient’s name
2. MRN number
3. Patient’s gender
4. Patient’s age or date of birth
5. Date & time test collected, performed and reported
6. Ordering Physician
7. Responsible physician (if not 6)
8. Reference or Target Range
9. Test Performed
10. Test units
11. Lab name
Vue de la page 1
1 2 3 4 5 6 7 ... 19 20

Commentaires sur ces manuels

Pas de commentaire